ProHealth health Resource
 SUBSCRIBE TO OUR FREE E-NEWSLETTERS  
Click Here to Preview
Log In
Catalog Quick Order
Your Account
Shopping Cart
 Check Out
ProHealth: News, Research, Vitamins & Supplements About ProHealth ProHealth ImmuneSupport.com ProHealth Online Vitamin & Supplement Store ProHealth Treatment & Research Library ProHealth Community ProHealth Vitamins & Supplements Catalog
Your Purchase Helps Fund Health Research
Explore Our Health Sites
ProHealth Vitamin and Supplement Catalog
Your resource for specialty nutritional supplements, books, DVDs, resources for better living, health news & more!
ProHealth Health & Wellness Research & News Catalog
Your Purchases Help Fund Ongoing Research
 
 
Search our extensive library for information, solutions & support
Site
Message Board  
Abstracts
Newsletters  
Articles
Products  

UCLA Study Shows PET Scan Detects Early Stages of Alzheimer’s Disease

November 19, 2001



Recent UCLA research shows that Positron Emission Tomography (PET) scans of the brain can accurately detect early Alzheimer's disease up to 95 percent of the time, helping patients receive prompt medical attention and treatment.

According to the Nov. 7 edition of the Journal of the American Medical Association, the UCLA team also found that PET is sensitive enough to predict whether persons experiencing age-related memory problems will or will not develop dementia in the future. This non-invasive medical procedure can help people decide if memory lapses might indicate something more serious.

In the largest PET scan study of Alzheimer's diagnosis to date, the researchers evaluated 284 patients at eight academic centers in the United States and Europe between 1984 and 2000. The UCLA team pooled data from brain PET scans, clinical follow-ups, and autopsy findings to judge PET as a tool for detecting and predicting Alzheimer’s disease.

"We wanted to test the sensitivity of PET in evaluating the brain for the presence of Alzheimer's disease and other dementias," explained Dr. Dan Silverman, principal investigator and UCLA assistant professor of pharmacology. "We found that PET opens a window into the living brain with a degree of accuracy matched only by autopsy."

Physicians monitored 146 of the patients for a period of two to nine years to determine whether or not they developed dementia. In the 138 other patients, physicians examined their brain tissue after death for signs of Alzheimer's disease and related dementias. In each case, the UCLA team compared the patient's final clinical outcome to its PET-based predictions.

Silverman and his colleagues found that PET accurately detected brain changes linked to Alzheimer's and other dementia the vast majority of the time. For example, PET correctly identified Alzheimer's in 95 percent of the patients in the earliest stages of dementia, and accurately foretold the disease in 93 percent of the patients later diagnosed with progressive dementia. In addition, PET correctly identified the presence of Alzheimer's disease in 94 percent of the diagnoses later confirmed by autopsy, and accurately predicted whether patients would or would not develop Alzheimer's disease in nearly 90 percent of all cases.

PET scans measure brain activity by revealing the amount of glucose metabolized in each region of the brain. A drop in metabolism indicates decreased activity in that region. Unlike other brain imaging techniques, PET scans can differentiate Alzheimer's disease from the normal effects of aging.

"PET's ability to diagnose dementia in its earliest stage holds great significance," Silverman said, "because medical management offers the most benefit during the initial period of decline."


"We believe that physicians can use PET to detect Alzheimer's disease with high sensitivity and accuracy -- even in its earliest stages," said Silverman. "Physicians can also use the scans to reassure people that their symptoms are not due to Alzheimer's or other neurodegenerative diseases that cause mental decline."

The UCLA team collaborated with researchers at UC Davis, UC Berkeley, the National Institute of Aging, Duke University, University of Pennsylvania, New York University, Universite de Liege in Belgium and the Max-Planck-Institut fur Neurologische Forschung in Koln, Germany.

The study was supported by grants from the National Institute on Aging, the Alzheimer's Disease Research Center of California, the U.S. Department of Energy, the Department of Radiology at Duke University and the Sidell-Kagen Foundation.









DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 
health Research Articles



[ Be the first to comment on this article ]




UCLA Study Shows PET Scan Detects Early Stages of Alzheimer’s Disease Article Tools
Print Page Print Page Email Article Email Article
Discuss Discuss
  Rate This
Most Viewed Articles & Abstracts
Clearing the Fog: Coping with the Cognitive Dysfunction of Fibromyalgia & Chronic Fatigue Syndrome [more]

Chocolate's Potential Health Benefits – and its Effect on Chronic Fatigue Syndrome Patients [more]

What Is Wrong with Artificial Sweeteners? [more]

Flu Shot Pros & Cons [more]

USDA Food Guide Pyramid [more]

Featured Vitamins, Supplements, and Health Products
Cuddle Ewe™ Essentials Set - King Cuddle Ewe™ Essentials Set - King
Price includes a $21 domestic shipping charge
Cuddle Ewe Travel Ewe™ Cuddle Ewe Travel Ewe™
20% discount not applied to $21 domestic shipping charge included in price.
Medical Organizer by Knock Knock Medical Organizer by Knock Knock
Chronicle appointment times, vital stats, treatment instructions and more
Cuddle Ewe™ Essentials Set - Full Cuddle Ewe™ Essentials Set - Full
Price includes a $21 domestic shipping charge
Cuddle Ewe™ Underquilt Slip Cover Cuddle Ewe™ Underquilt Slip Cover
100% Cotton fabric
Security Enabled AlertSite is a leading provider of Web site monitoring and performance management solutions that help businesses ensure optimum Web experiences for their customers. TrustE Better Business Bureau BizRate Customer Certified (GOLD) Site
ProHealth Vitamin and Supplement SmartSavings Club

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ADVANCED MEDICAL LABS   |   WHOLESALE   |   AFFILIATES   |   CONTACT US   |   PRIVACY   |   GLOSSARY   |   CUSTOMER SERVICE   |   RELATED SITES   |   RSS
Email us or Call toll-free 800-366-6056 · Monday through Friday, 7 a.m.-5 p.m. Pacific Time
International Callers dial 001.805.564.3064
Copyright © 2008 ProHealth, Inc.